MAIA Biotechnology Inc (AMEX: MAIA) on Monday, soared 7.08% from the previous trading day, before settling in for the closing price of $2.12. Within the past 52 weeks, MAIA’s price has moved between $0.99 and $5.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -7.69%. With a float of $20.92 million, this company’s outstanding shares have now reached $23.97 million.
Let’s look at the performance matrix of the company that is accounted for 13 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MAIA Biotechnology Inc (MAIA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of MAIA Biotechnology Inc is 17.42%, while institutional ownership is 5.79%. The most recent insider transaction that took place on Dec 13 ’24, was worth 46,800. In this transaction Director of this company bought 25,000 shares at a rate of $1.87, taking the stock ownership to the 1,130,060 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director bought 53,418 for $1.87, making the entire transaction worth $99,998. This insider now owns 514,970 shares in total.
MAIA Biotechnology Inc (MAIA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.69% per share during the next fiscal year.
MAIA Biotechnology Inc (AMEX: MAIA) Trading Performance Indicators
MAIA Biotechnology Inc (MAIA) is currently performing well based on its current performance indicators. A quick ratio of 2.56 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of MAIA Biotechnology Inc (MAIA)
MAIA Biotechnology Inc (AMEX: MAIA) saw its 5-day average volume 0.89 million, a positive change from its year-to-date volume of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 38.33%. Additionally, its Average True Range was 0.23.
During the past 100 days, MAIA Biotechnology Inc’s (MAIA) raw stochastic average was set at 24.20%, which indicates a significant decrease from 55.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.69% in the past 14 days, which was higher than the 84.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.28, while its 200-day Moving Average is $2.86. Nevertheless, the first resistance level for the watch stands at $2.46 in the near term. At $2.66, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.87. If the price goes on to break the first support level at $2.05, it is likely to go to the next support level at $1.84. The third support level lies at $1.64 if the price breaches the second support level.
MAIA Biotechnology Inc (AMEX: MAIA) Key Stats
Market capitalization of the company is 57.50 million based on 26,158K outstanding shares. Right now, sales total 0 K and income totals -19,770 K. The company made 0 K in profit during its latest quarter, and -2,740 K in sales during its previous quarter.
